BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 21729805)

  • 21. Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects.
    Hyun SJ; Han DK; Choi SH; Chai JK; Cho KS; Kim CK; Kim CS
    J Periodontol; 2005 Oct; 76(10):1667-74. PubMed ID: 16253088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation.
    Triplett RG; Nevins M; Marx RE; Spagnoli DB; Oates TW; Moy PK; Boyne PJ
    J Oral Maxillofac Surg; 2009 Sep; 67(9):1947-60. PubMed ID: 19686934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced effects of BMP-binding peptide combined with recombinant human BMP-2 on the healing of a rodent segmental femoral defect.
    Morishita Y; Naito M; Miyazaki M; He W; Wu G; Wei F; Sintuu C; Hymanson H; Brochmann EJ; Murray SS; Wang JC
    J Orthop Res; 2010 Feb; 28(2):258-64. PubMed ID: 19639633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model.
    Fischgrund JS; James SB; Chabot MC; Hankin R; Herkowitz HN; Wozney JM; Shirkhoda A
    J Spinal Disord; 1997 Dec; 10(6):467-72. PubMed ID: 9438810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient soft-tissue edema associated with implantation of increasing doses of rhBMP-2 on an absorbable collagen sponge in an ectopic rat model.
    Bae HW; Strenge KB; Ashraf N; Badura JM; Peckham SM; McKay WF
    J Bone Joint Surg Am; 2012 Oct; 94(20):1845-52. PubMed ID: 23079876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
    J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimizing the severity of rhBMP-2-induced inflammation and heterotopic ossification with a polyelectrolyte carrier incorporating heparin on microbead templates.
    Wang M; Abbah SA; Hu T; Toh SY; Lam RW; Goh JC; Wong HK
    Spine (Phila Pa 1976); 2013 Aug; 38(17):1452-8. PubMed ID: 23380826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone morphogenetic protein-2 and spinal arthrodesis: the basic science perspective on protein interaction with the nervous system.
    Dmitriev AE; Lehman RA; Symes AJ
    Spine J; 2011 Jun; 11(6):500-5. PubMed ID: 21729799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BMP-2 adverse reactions treated with human dose equivalent dexamethasone in a rodent model of soft-tissue inflammation.
    Xiong C; Daubs MD; Montgomery SR; Aghdasi B; Inoue H; Tian H; Suzuki A; Tan Y; Hayashi T; Ruangchainikom M; Chai T; Corey M; Wang JC
    Spine (Phila Pa 1976); 2013 Sep; 38(19):1640-7. PubMed ID: 23715023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin-induced bone morphogenetic protein (BMP) 2 expression during bone regeneration: an immunohistochemical study.
    Alam S; Ueki K; Nakagawa K; Marukawa K; Hashiba Y; Yamamoto E; Sakulsak N; Iseki S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jan; 107(1):22-9. PubMed ID: 18755616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BMP-2/7 heterodimer strongly induces bone regeneration in the absence of increased soft tissue inflammation.
    Kaito T; Morimoto T; Mori Y; Kanayama S; Makino T; Takenaka S; Sakai Y; Otsuru S; Yoshioka Y; Yoshikawa H
    Spine J; 2018 Jan; 18(1):139-146. PubMed ID: 28735764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
    Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
    J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of two doses of recombinant human bone morphogenetic protein in absorbable collagen sponges for bone healing in dogs.
    Schmiedt CW; Lu Y; Heaney K; Muir P; Amodie DM; Markel MD
    Am J Vet Res; 2007 Aug; 68(8):834-40. PubMed ID: 17669023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Periodontal repair in dogs: effect of recombinant human bone morphogenetic protein-12 (rhBMP-12) on regeneration of alveolar bone and periodontal attachment.
    Wikesjö UM; Sorensen RG; Kinoshita A; Jian Li X; Wozney JM
    J Clin Periodontol; 2004 Aug; 31(8):662-70. PubMed ID: 15257745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast growth factor-2 augments recombinant human bone morphogenetic protein-2-induced osteoinductive activity.
    Tanaka E; Ishino Y; Sasaki A; Hasegawa T; Watanabe M; Dalla-Bona DA; Yamano E; van Eijden TM; Tanne K
    Ann Biomed Eng; 2006 May; 34(5):717-25. PubMed ID: 16568346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier.
    Lee JH; Yu CH; Yang JJ; Baek HR; Lee KM; Koo TY; Chang BS; Lee CK
    Spine J; 2012 Mar; 12(3):239-48. PubMed ID: 22341396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axonal loss in murine peripheral nerves following exposure to recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge.
    Margolis DS; Wu EW; Truchan LM
    J Bone Joint Surg Am; 2013 Apr; 95(7):611-9. PubMed ID: 23553296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved healing efficacy in canine ulnar segmental defects with increasing recombinant human bone morphogenetic protein-2/allograft ratios.
    Jones CB; Sabatino CT; Badura JM; Sietsema DL; Marotta JS
    J Orthop Trauma; 2008 Sep; 22(8):550-9. PubMed ID: 18758287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR; Glassman SD; Burkus KJ; Carreon LY
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects.
    Hong SJ; Kim CS; Han DK; Cho IH; Jung UW; Choi SH; Kim CK; Cho KS
    Biomaterials; 2006 Jul; 27(20):3810-6. PubMed ID: 16574220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.